Credit Suisse
-
Malaysian poultry producer Leong Hup International has started early stage engagement with the buy-side and is looking for cornerstone investors for its IPO, according to a source close to the deal.
-
Guangzhou R&F Properties Co started the new year by tackling its upcoming bond maturity head on, selling a $500m note on Thursday to refinance a February deal.
-
VPBank Finance has made a quick comeback to the international syndications market for a $130m borrowing with a short one year tenor.
-
Malaysian poultry producer Leong Hup International is planning to start pre-marketing for its $500m IPO next week, according to a source close to the matter.
-
Zurich-based syndicate heads entered the new year cautiously optimistic about the outlook for Swiss franc bond issuance in 2019.
-
Sandeep Agarwal, a veteran of the financial institutions bond market, has parted ways with Credit Suisse to join a new company.
-
Futu Holdings, parent of Hong Kong-based Futu Securities International, is planning a Nasdaq IPO of up to $300m.
-
The European Commission said on Thursday that it had informed four banks that have, in its view, breached European Union antitrust rules in trading SSA bonds in the secondary market that it is investigating them.
-
As central banks retreat from public markets, spreads are widening in dollars and euros, and cross-currency basis swaps are improving for international borrowers, Swiss bankers believe the good times might be returning to a market once known the world over for diversification and arbitrage.
-
Chinese property companies are pushing their fund-raising for 2018 to the bitter end – with sometimes surprising results. Cifi Holdings scored with a larger-than-expected $400m bond on Monday, while Redsun Properties Group sold a $200m tap.
-
Shanghai Junshi Biosciences has raised HK$3.08bn ($394.2m) after pricing its IPO at the bottom of the range, according to a banker on the deal.
-
Credit Suisse used part of an investor day on Wednesday to offer a staunch defence of its leveraged finance business, which forms a larger part of its investment banking and markets business than at its major competitors, but which has seen increasing regulatory scrutiny this year.